William Gordon III

William Gordon III is a distinguished professional with a robust educational background and extensive experience in various leadership roles. Graduating from the University of Pennsylvania Wharton School with an MBA in Finance, he furthered his studies at UC Berkeley, earning a PhD in Molecular Biology. His research at Cold Spring Harbor Labs under the guidance of James Watson and Barbara McClintock showcases his dedication to scientific exploration.

Aside from his academic achievements, William Gordon III has made significant contributions in the business world as a serial entrepreneur, angel investor, and mentor. His career has seen him take on pivotal roles such as CEO, CFO, and COO in multiple companies. Notably, his tenure as the COO of a medical device company specializing in Alzheimer’s disease therapeutics was marked by remarkable achievements, including assembling a proficient team, securing funding through two rounds of convertible notes, and obtaining FDA Breakthrough Device status in a record time.

In addition to his corporate endeavors, William has been actively involved in academia and consultancy. He has served as a Technology Business Advisor at the CT SBDC, sharing his valuable insights with aspiring entrepreneurs. His diverse professional journey also includes roles as a Biotechnology Consultant, Graduate Faculty member, and Co-Founder in various innovative ventures.